Literature DB >> 29776727

Promise and Challenges of Using Combined Moderator Methods to Personalize Mental Health Treatment.

Meredith L Wallace1, Stephen F Smagula2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29776727      PMCID： PMC6292524          DOI： 10.1016/j.jagp.2018.02.001

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN： 1064-7481            Impact factor:   4.105


× No keyword cloud information.
  8 in total

1.  Evaluation of comparative treatment trials: assessing clinical benefits and risks for patients, rather than statistical effects on measures.

Authors:  Helena Chmura Kraemer; Ellen Frank
Journal:  JAMA       Date:  2010-08-11       Impact factor: 56.272

2.  Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.

Authors:  Stephen F Smagula; Meredith L Wallace; Stewart J Anderson; Jordan F Karp; Eric J Lenze; Benoit H Mulsant; Meryl A Butters; Daniel M Blumberger; Breno S Diniz; Francis E Lotrich; Mary Amanda Dew; Charles F Reynolds
Journal:  J Psychiatr Res       Date:  2016-07-07       Impact factor: 4.791

3.  Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach.

Authors:  Helena Chmura Kraemer
Journal:  Stat Med       Date:  2013-01-10       Impact factor: 2.373

4.  The role of day-to-day emotions, sleep, and social interactions in pediatric anxiety treatment.

Authors:  Meredith L Wallace; Dana L McMakin; Patricia Z Tan; Dana Rosen; Erika E Forbes; Cecile D Ladouceur; Neal D Ryan; Greg J Siegle; Ronald E Dahl; Philip C Kendall; Anthony Mannarino; Jennifer S Silk
Journal:  Behav Res Ther       Date:  2016-12-18

5.  Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.

Authors:  Shriya H Kaneriya; Gregg A Robbins-Welty; Stephen F Smagula; Jordan F Karp; Meryl A Butters; Eric J Lenze; Benoit H Mulsant; Daniel Blumberger; Stewart J Anderson; Mary Amanda Dew; Francis Lotrich; Howard J Aizenstein; Breno S Diniz; Charles F Reynolds
Journal:  JAMA Psychiatry       Date:  2016-04       Impact factor: 21.596

6.  Applying a novel statistical method to advance the personalized treatment of anxiety disorders: A composite moderator of comparative drop-out from CBT and ACT.

Authors:  Andrea N Niles; Kate B Wolitzky-Taylor; Joanna J Arch; Michelle G Craske
Journal:  Behav Res Ther       Date:  2017-01-04

7.  A Machine Learning Approach to Identifying Placebo Responders in Late-Life Depression Trials.

Authors:  Sigal Zilcha-Mano; Steven P Roose; Patrick J Brown; Bret R Rutherford
Journal:  Am J Geriatr Psychiatry       Date:  2018-01-11       Impact factor: 4.105

8.  A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials.

Authors:  Meredith L Wallace; Ellen Frank; Helena C Kraemer
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 25.911
  8 in total
  2 in total

1.  Who benefits most from expectancy effects? A combined neuroimaging and antidepressant trial in depressed older adults.

Authors:  Sigal Zilcha-Mano; Meredith L Wallace; Patrick J Brown; Joel Sneed; Steven P Roose; Bret R Rutherford
Journal:  Transl Psychiatry       Date:  2021-09-15       Impact factor: 7.989

2.  Predictors and moderators of treatment efficacy in reducing custodial grandmothers' psychological distress.

Authors:  Gregory C Smith; Gregory R Hancock; Bert Hayslip
Journal:  Aging Ment Health       Date:  2021-01-04       Impact factor: 3.658
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.